Dr. Moshe Levy
Claim this profileTexas Oncology - Baylor Charles A. Sammons Cancer Center
Studies Leukemia
Studies Lymphoma
15 reported clinical trials
34 drugs studied
Area of expertise
1Leukemia
FLT3 positive
BCR-ABL1 positive
BCR-ABL1 e13a2 positive
2Lymphoma
EZH2 positive
CNG positive
CNG negative
Affiliated Hospitals
Clinical Trials Moshe Levy is currently running
Pirtobrutinib + VR
for Chronic Lymphocytic Leukemia
The purpose of this study is to compare the efficacy and safety of fixed duration pirtobruitinib (LOXO-305) with VR (Arm A) compared to VR alone (Arm B) in patients with CLL/SLL who have been previously treated with at least one prior line of therapy. Participation could last up to five years.
Recruiting2 awards Phase 3
Tazemetostat + Lenalidomide + Rituximab
for Follicular Lymphoma
The participants of this study would have relapsed/refractory follicular lymphoma. Follicular lymphoma is a type of blood cancer. It is referred to as 'relapsed' when the disease has come back after a period of improvement after that follows a treatment regimen and 'refractory' when treatment no longer works. Stage 1 of this trial will study the safety and the level that adverse effects of each of the study drug combinations can be tolerated (known as tolerability). It is also designed to establish a recommended study drug dosage for stage 2 and 3. Stage 1 of the study is completed. Stages 2 and 3 will evaluate and compare how long participants live without their disease getting worse when receiving the study drug in combination with other drug treatment versus the placebo (dummy drug) in combination with other drug treatment.
Recruiting1 award Phase 34 criteria
More about Moshe Levy
Clinical Trial Related1 year of experience running clinical trials · Led 15 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Moshe Levy has experience with
- Azacitidine
- Lenalidomide
- Venetoclax
- Rituximab
- Gilteritinib
- Lanraplenib
Breakdown of trials Moshe Levy has run
Leukemia
Lymphoma
Acute Myeloid Leukemia
Multiple Myeloma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Moshe Levy specialize in?
Moshe Levy focuses on Leukemia and Lymphoma. In particular, much of their work with Leukemia has involved FLT3 positive patients, or patients who are BCR-ABL1 positive.
Is Moshe Levy currently recruiting for clinical trials?
Yes, Moshe Levy is currently recruiting for 5 clinical trials in Dallas Texas. If you're interested in participating, you should apply.
Are there any treatments that Moshe Levy has studied deeply?
Yes, Moshe Levy has studied treatments such as Azacitidine, Lenalidomide, Venetoclax.
What is the best way to schedule an appointment with Moshe Levy?
Apply for one of the trials that Moshe Levy is conducting.
What is the office address of Moshe Levy?
The office of Moshe Levy is located at: Texas Oncology - Baylor Charles A. Sammons Cancer Center, Dallas, Texas 75246 United States. This is the address for their practice at the Texas Oncology - Baylor Charles A. Sammons Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.